Senate bill mentions DTx. Pear lobbying. FDA vs payers.

Issue 022.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a lucky 77 percent open rate. Here's what's happening this week:

Excited to announce that these past seven days were E&O's best week ever for new subscribers! Thanks to all the current readers who have encouraged colleagues to sign up. If you are new here: Feel free to reply to this newsletter to send feedback my way. Don't be shy, it makes this better for everyone.
Seed investor Rock Health announced that funding for digital health startups slowed down in Q3, which saw $1.3 billion flowing into the sector after two quarters that averaged $2 billion each. Current funding for the year stands at more than $5.5 billion.
Meanwhile, the digital health moon shooters over at StartUp Health have tracked $10.4 billion in digital health funding so far this year. They did,

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Senate bill mentions DTx. Pear lobbying. FDA vs payers.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.